KR930017874A - 포화 질소 헤테로사이클의 유도체 - Google Patents
포화 질소 헤테로사이클의 유도체 Download PDFInfo
- Publication number
- KR930017874A KR930017874A KR1019930002171A KR930002171A KR930017874A KR 930017874 A KR930017874 A KR 930017874A KR 1019930002171 A KR1019930002171 A KR 1019930002171A KR 930002171 A KR930002171 A KR 930002171A KR 930017874 A KR930017874 A KR 930017874A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- salt
- pharmaceutically acceptable
- radical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH46092 | 1992-02-17 | ||
| CH00460/92-0 | 1992-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR930017874A true KR930017874A (ko) | 1993-09-20 |
Family
ID=4187521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019930002171A Withdrawn KR930017874A (ko) | 1992-02-17 | 1993-02-17 | 포화 질소 헤테로사이클의 유도체 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5322852A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0558443A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH069558A (cg-RX-API-DMAC10.html) |
| KR (1) | KR930017874A (cg-RX-API-DMAC10.html) |
| AU (1) | AU3298193A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2089533A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL104757A0 (cg-RX-API-DMAC10.html) |
| TW (1) | TW214545B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA931064B (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834486A (en) * | 1995-03-15 | 1998-11-10 | Novartis Ag | Piperidinyl-2-alkyl, substituted linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation |
| TWI220143B (en) * | 1998-05-13 | 2004-08-11 | Solvay Pharm Gmbh | Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products |
| JP5583592B2 (ja) | 2007-11-30 | 2014-09-03 | ニューリンク ジェネティクス コーポレイション | Ｉｄｏ阻害剤 |
| TWI386395B (zh) * | 2008-12-15 | 2013-02-21 | Taigen Biotechnology Co Ltd | 哌啶衍生物的立體有擇合成 |
| JP5505175B2 (ja) | 2009-07-31 | 2014-05-28 | Ｊｓｒ株式会社 | 感放射線性樹脂組成物およびそれに用いられる化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| EP0369944A1 (de) * | 1988-11-18 | 1990-05-23 | Ciba-Geigy Ag | Substituierte Oxadiaminobutane |
| FR2644456B1 (fr) * | 1989-03-17 | 1991-07-05 | Rhone Poulenc Sante | Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent |
| IL97759A0 (en) * | 1990-04-11 | 1992-06-21 | Ciba Geigy Ag | Hydroxylamine compounds |
| EP0495750A3 (en) * | 1991-01-14 | 1992-09-16 | Ciba-Geigy Ag | Heterocyclic hydroxylamine |
-
1993
- 1993-01-30 TW TW082100576A patent/TW214545B/zh active
- 1993-02-09 EP EP93810079A patent/EP0558443A1/de not_active Withdrawn
- 1993-02-10 AU AU32981/93A patent/AU3298193A/en not_active Abandoned
- 1993-02-11 US US08/016,407 patent/US5322852A/en not_active Expired - Lifetime
- 1993-02-15 CA CA002089533A patent/CA2089533A1/en not_active Abandoned
- 1993-02-16 ZA ZA931064A patent/ZA931064B/xx unknown
- 1993-02-16 JP JP5026685A patent/JPH069558A/ja active Pending
- 1993-02-16 IL IL104757A patent/IL104757A0/xx unknown
- 1993-02-17 KR KR1019930002171A patent/KR930017874A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2089533A1 (en) | 1993-08-18 |
| IL104757A0 (en) | 1993-06-10 |
| EP0558443A1 (de) | 1993-09-01 |
| US5322852A (en) | 1994-06-21 |
| AU3298193A (en) | 1993-08-19 |
| JPH069558A (ja) | 1994-01-18 |
| TW214545B (cg-RX-API-DMAC10.html) | 1993-10-11 |
| ZA931064B (en) | 1993-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002476A2 (hu) | Aminvegyületek, előállításuk és alkalmazásuk | |
| KR960007545A (ko) | 합성 흥분성 아미노산 | |
| HUP0004040A1 (hu) | Antimikrobiális hatású pleuromutilinszármazékok, eljárás ezek előállítására, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| HUP9901209A2 (hu) | Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE71625T1 (de) | Imidazoheterocyclische verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| MY100300A (en) | Antimycotic nail varnish | |
| DK0915866T3 (da) | Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre | |
| TNSN97212A1 (fr) | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
| RU95104885A (ru) | 1h-индол-3-глиоксиламиды, ингибирующие spla2-медируемое выделение жирных кислот, фармацевтическая композиция | |
| FI941987A0 (fi) | Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset | |
| HUP9802630A2 (hu) | Királis metil-fenil-oxazolidinonok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| KR910011895A (ko) | 약제 | |
| DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| ATE63124T1 (de) | Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung. | |
| EP1108428A3 (en) | Compositions for and uses thereof for treating viral disease with phenylacetate and derivatives thereof | |
| HUT65351A (en) | Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent | |
| KR900004658A (ko) | 이치환 벤질아민, 그의 제조방법, 약제로서의 그의 용도 및 그의 합성 약제 | |
| MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
| ATE19773T1 (de) | Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung. | |
| KR910000607A (ko) | 새로운 에스테르 | |
| EP1122252A4 (en) | CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM | |
| KR930017874A (ko) | 포화 질소 헤테로사이클의 유도체 | |
| CA2486872A1 (en) | Nf-kb inhibitors and uses thereof | |
| KR900011724A (ko) | 특정 피롤릴페닐-치환된 하이드록삼산 유도체 | |
| GR78771B (cg-RX-API-DMAC10.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19930217 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |